Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Perspective Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CATX.
You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.
Other companies in Perspective Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), Quoin Pharmaceuticals (NASDAQ:QNRX) and 4D Molecular Therapeutics (NASDAQ:FDMT).
Perspective Therapeutics has a consensus price target of $9.85.
The stock price for Perspective Therapeutics (AMEX: CATX) is $2 last updated April 17, 2025 at 4:31 PM EDT.
There are no upcoming dividends for Perspective Therapeutics.
Perspective Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
There is no upcoming split for Perspective Therapeutics.
Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.